Belgium | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Belgium totalled $ 60 billion in 2023. Sales of commodity group 30 from Belgium decreased by 20% in value terms compared to 2022. exports of commodity group 30 "Pharmaceutical products" decreased by $ 15.7 billion (cumulative exports of commodity group 30 from Belgium amounted $76 billion in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 15.3% of total exports from Belgium (cumulative merchandise exports from Belgium totalled $ 393 billion in 2023). The share of commodity group 30 in total exports from Belgium decreased by 1.05 p.p. compared to 2022 (it was 16.4% in 2022 and cumulative exports from Belgium were equal to $ 463 billion).
Where does Belgium export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Belgium in 2023:
- USA with a share of 23% (14.2 billion US$)
- Germany with a share of 9.15% (5.53 billion US$)
- Netherlands with a share of 7.7% (4.66 billion US$)
- Italy with a share of 7.11% (4.3 billion US$)
- United Kingdom with a share of 5.87% (3.55 billion US$)
- France with a share of 4.65% (2.81 billion US$)
- Japan with a share of 3.69% (2.23 billion US$)
- China with a share of 3.52% (2.13 billion US$)
- Spain with a share of 3.03% (1.83 billion US$)
- Russia with a share of 1.94% (1.17 billion US$)
Exports structure of 30 - Pharmaceutical products - from Belgium in 2023 represented by the following main commodity groups:
- 48% (29 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 46% (28 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 2.46% (1.49 billion US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 2.1% (1.27 billion US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.346% (209 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.04% (24 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
The value of imports of commodity group 30 "Pharmaceutical products" to Belgium totalled $ 53 billion in 2023. Sales of commodity group 30 to Belgium went up by 11.1% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 5.38 billion (the value of imports of commodity group 30 to Belgium was equal to $48 billion in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 12.9% of total import flow to Belgium (in 2023, total imports to Belgium amounted to $ 415 billion). The share of commodity group 30 in total imports to Belgium increased by 2.53 p.p. compared to 2022 (it was 10.4% in 2022 and cumulative imports to Belgium were equal to $ 464 billion).
Where does Belgium import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Belgium in 2023:
- Ireland with a share of 22% (12.2 billion US$)
- USA with a share of 21% (11.6 billion US$)
- Switzerland with a share of 16.3% (8.77 billion US$)
- Italy with a share of 11.7% (6.31 billion US$)
- Germany with a share of 9.37% (5.03 billion US$)
- France with a share of 7.33% (3.94 billion US$)
- Netherlands with a share of 2.57% (1.38 billion US$)
- United Kingdom with a share of 1.26% (678 million US$)
- Singapore with a share of 1.09% (586 million US$)
- Spain - 436 million US$
Imports structure of 30 - Pharmaceutical products - to Belgium in 2023 represented by the following main commodity groups:
- 49% (26 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 41% (22 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 7.02% (3.77 billion US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 1.91% (1.02 billion US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.364% (195 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
- 0.313% (168 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
